SOM Innovation Biotech SL – Product Pipeline Review – 2015

$1,500

Global Markets Direct’s, ‘SOM Innovation Biotech SL – Product Pipeline Review – 2015’, provides an overview of the SOM Innovation Biotech SL’s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of SOM Innovation Biotech SL’s, complete with comparative analysis at various stages…..

Total Pages: 32

Global Markets Direct’s, ‘SOM Innovation Biotech SL - Product Pipeline Review - 2015’, provides an overview of the SOM Innovation Biotech SL’s pharmaceutical research and development focus.
This report provides comprehensive information on the current therapeutic developmental pipeline of SOM Innovation Biotech SL’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of SOM Innovation Biotech SL including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of SOM Innovation Biotech SL’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the SOM Innovation Biotech SL’s pipeline products

Reasons to buy

- Evaluate SOM Innovation Biotech SL’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of SOM Innovation Biotech SL in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the SOM Innovation Biotech SL’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of SOM Innovation Biotech SL and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of SOM Innovation Biotech SL
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of SOM Innovation Biotech SL and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
SOM Innovation Biotech SL Snapshot 5
SOM Innovation Biotech SL Overview 5
Key Information 5
Key Facts 5
SOM Innovation Biotech SL - Research and Development Overview 6
Key Therapeutic Areas 6
SOM Innovation Biotech SL - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
SOM Innovation Biotech SL - Pipeline Products Glance 12
SOM Innovation Biotech SL - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
SOM Innovation Biotech SL - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Discovery Products/Combination Treatment Modalities 15
SOM Innovation Biotech SL - Drug Profiles 16
tolcapone 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
SOM-3355 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
SOM-2391 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
SOM-2393 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
lestaurtinib 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
SOM-2485 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
SOM-7400 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
SOM Innovation Biotech SL - Pipeline Analysis 24
SOM Innovation Biotech SL - Pipeline Products by Target 24
SOM Innovation Biotech SL - Pipeline Products by Route of Administration 25
SOM Innovation Biotech SL - Pipeline Products by Molecule Type 26
SOM Innovation Biotech SL - Pipeline Products by Mechanism of Action 27
SOM Innovation Biotech SL - Recent Pipeline Updates 28
SOM Innovation Biotech SL - Dormant Projects 29
SOM Innovation Biotech SL - Dormant Projects 29
SOM Innovation Biotech SL - Locations And Subsidiaries 30
Head Office 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 31
Disclaimer 32

List of Tables
SOM Innovation Biotech SL, Key Information 5
SOM Innovation Biotech SL, Key Facts 5
SOM Innovation Biotech SL - Pipeline by Indication, 2015 7
SOM Innovation Biotech SL - Pipeline by Stage of Development, 2015 8
SOM Innovation Biotech SL - Monotherapy Products in Pipeline, 2015 9
SOM Innovation Biotech SL - Out-Licensed Products in Pipeline, 2015 10
SOM Innovation Biotech SL - Out-Licensed Products/ Combination Treatment Modalities, 2015 11
SOM Innovation Biotech SL - Phase II, 2015 12
SOM Innovation Biotech SL - Phase I, 2015 13
SOM Innovation Biotech SL - Preclinical, 2015 14
SOM Innovation Biotech SL - Discovery, 2015 15
SOM Innovation Biotech SL - Pipeline by Target, 2015 24
SOM Innovation Biotech SL - Pipeline by Route of Administration, 2015 25
SOM Innovation Biotech SL - Pipeline by Molecule Type, 2015 26
SOM Innovation Biotech SL - Pipeline Products by Mechanism of Action, 2015 27
SOM Innovation Biotech SL - Recent Pipeline Updates, 2015 28
SOM Innovation Biotech SL - Dormant Developmental Projects,2015 29

List of Figures
SOM Innovation Biotech SL - Pipeline by Top 10 Indication, 2015 7
SOM Innovation Biotech SL - Pipeline by Stage of Development, 2015 8
SOM Innovation Biotech SL - Monotherapy Products in Pipeline, 2015 9
SOM Innovation Biotech SL - Pipeline by Top 10 Target, 2015 24
SOM Innovation Biotech SL - Pipeline by Top 10 Molecule Type, 2015 26
SOM Innovation Biotech SL - Pipeline Products by Top 10 Mechanism of Action, 2015 27


LICENSE TYPE